Aminoalkylphosphonates and related compounds as Edg receptor agonists
US7309721B2 · kind B2 · utility
18Cited by
4References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 27, 2003 |
| Grant date | Dec 18, 2007 |
| Priority date | — |
| Expiry date | Apr 2, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/3882
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention encompasses compounds or Formula (I): as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.